Analyst Ratings for Emergent BioSolutions (EBS)
EBS Rating Summary
EBS Price Target Summary
- Highest: $31.00 (Wedbush)
- Lowest: $19.00 (RBC Capital)
- Average: $23.50
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$23.50 (+62.4%)
Avg. $ Target:
$23.50 (+62.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/11/2013 | Janney Montgomery Scott | New Coverage | Buy (N/A) |
20.00 (N/A) |
13.76 | 14.47 | 5.16% | Details |
| 6/11/2012 | RBC Capital | New Coverage | Sector Perform (N/A) |
19.00 (N/A) |
13.97 | 14.47 | 3.58% | Details |
| 6/11/2012 | Piper Jaffray | New Coverage | Overweight (N/A) |
21.00 (N/A) |
13.97 | 14.47 | 3.58% | Details |
| 12/29/2011 | Caris & Co. | New Coverage | Buy (N/A) |
24.00 (N/A) |
16.53 | 14.47 | -12.46% | Details |
| 10/6/2011 | ThinkEquity | New Coverage | Buy (N/A) |
26.00 (N/A) |
16.98 | 14.47 | -14.78% | Details |
| 8/18/2010 | WBB Securities | Upgrade | Strong Buy (N/A) |
N/A (N/A) |
17.54 | 14.47 | -17.5% | Details |
